BioCentury | Oct 2, 2020
Distillery Therapeutics

IL-12B monomers to treat multiple sclerosis, rheumatoid arthritis

...monomer reduced disease scores, paw swelling and paw thickness, and improved locomotor activity.TARGET/MARKER/PATHWAY: Interleukin-12B (IL-12B); interleukin-12 receptor...
...Aug. 19, 2020doi:10.1073/pnas.2000653117CONTACT: Kalipada Pahan, Rush University Medical Center, Chicago, Ill.email: kalipada_pahan@rush.edu Sandi Wong Rush University Medical Center Interleukin-12B (IL-12B) Interleukin-12 receptor...
BioCentury | Sep 18, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Dermatology Dermatitis Interleukin 12 receptor, b2 (IL12RB2); toll-like receptor 2 (TLR2); TLR4 Mouse studies suggest that antagonizing both IL12RB2 and TLR4 may...
BioCentury | May 20, 2002
Company News

Histogenics Inc. other research news

...addition, they found that T-bet mediates STAT1-dependent processes of TH1 development, including the induction of interleukin-12 receptor...
Items per page:
1 - 3 of 3